Metformin does not improve survival in patients with hepatocellular carcinoma

AIM: To assess whether metformin, which has a chemopreventive effect in chronic liver disease, has any chemotherapeutic effect in hepatocellular carcinoma. METHODS: This was a retrospective study of 701 patients with newly diagnosed hepatocellular carcinoma (HCC) seen between January 2005 and June 2...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:World J Gastroenterol
Asıl Yazarlar: Bhat, Mamatha, Chaiteerakij, Roongruedee, Harmsen, William S, Schleck, Cathy D, Yang, Ju Dong, Giama, Nasra H, Therneau, Terry M, Gores, Gregory J, Roberts, Lewis R
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Baishideng Publishing Group Inc 2014
Konular:
Retrospective Study
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229540/
https://ncbi.nlm.nih.gov/pubmed/25400459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i42.15750
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller